Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.
Edgewood Oncology has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Edgewood Oncology's investors include Alta Partners.
Edgewood Oncology is headquartered in Brookline, United States.
Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.
Edgewood Oncology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Edgewood Oncology — Funding & Investors." VCBacked, March 25, 2024, https://www.vcbacked.co/company/edgewood-oncology. Accessed August 14, 2026.
VCBacked. (2024). Edgewood Oncology — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/edgewood-oncology
{{cite web |title=Edgewood Oncology — Funding & Investors |url=https://www.vcbacked.co/company/edgewood-oncology |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated